Lebowitz, Peter F <br/><br/>
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 2005 
 - 1247-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alkyl and Aryl Transferases--antagonists & inhibitors<br/>Anemia--chemically induced<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Area Under Curve<br/>Breast Neoplasms--drug therapy<br/>Dose-Response Relationship, Drug<br/>Exanthema--chemically induced<br/>Farnesyltranstransferase<br/>Fatigue--chemically induced<br/>Female<br/>Humans<br/>Leukocytes, Mononuclear--drug effects<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Quinolones--administration & dosage<br/>Tamoxifen--administration & dosage<br/>Treatment Outcome